NextPlat Corp Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)																	12 Months Ended
	Dec. 14, 2022 USD ($) $ / shares	Dec. 09, 2022 $ / shares shares	Dec. 09, 2022 USD ($) $ / shares shares	Nov. 16, 2022 USD ($)	Sep. 02, 2022 USD ($) $ / shares shares	Jan. 05, 2022 USD ($) shares	Jun. 28, 2021 USD ($) shares	Jun. 02, 2021 USD ($) $ / shares shares	Jun. 02, 2021 USD ($) $ / shares shares	May 28, 2021	May 28, 2021	Aug. 19, 2019	Mar. 06, 2019	Mar. 08, 2018	Mar. 28, 2014	Apr. 21, 2010	Dec. 14, 2023 shares	Dec. 31, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares	Jan. 21, 2022 $ / shares
Reverse stock split issued and outstanding										ratio of 1-for-5	1-for-5	reverse split of our common stock at a ratio of 1 for 15	1-for-200 reverse stock split	reverse split of our common stock at a ratio of 1 for 150
Common stock, par value \| $ / shares	$ 0.0001																	$ 0.0001	$ 0.0001	$ 0.0001
Stock issued during period shares new issues \| shares						2,229,950
Issued during period value new issues						$ 5,825,038
Warrants exercise price \| $ / shares	$ 1.75
Common stock shares issued \| shares																		14,402,025	7,053,146
Proceeds from sale of common stock \| shares									2,880,000
Sale of stock price per share \| $ / shares								$ 5.00	$ 5.00
Proceeds from Issuance Initial Public Offering	$ 8,000,000.0								$ 14,404,666									$ 7,200,000	$ 1,400,000
Proceeds from warrants																			4,320
Proceeds from issuance of common stock									$ 14,404,666										12,661,984
Cash, uninsured amount																		18,290,725
Allowance for doubtful accounts receivable																		0	0
Prepaid expenses current																		45,679	97,068
Prepaid expenses long term																		49,078	49,867
Contract liabilities																		36,415	36,765
Advertising Expense																		$ 92,549	61,922
Intangible asset, amortization period																		10 years
Depreciation expense																		$ 465,059	$ 292,102
Income tax examination, description																		Tax positions that meet the more likely than not recognition threshold is measured at the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority.
US$: GBP [Member] \| Closing Rate [Member]
Foreign currency translation rate																		1.2098	1.353372
US$: GBP [Member] \| Yearly Average Rate [Member]
Foreign currency translation rate																		1.2369	1.375083
June Offering [Member]
Warrants exercise price \| $ / shares								$ 5.00	$ 5.00
Warrants to purchase common stock \| shares								432,000	432,000
Warrant price per share \| $ / shares								$ 0.01	$ 0.01
Warrants term								5 years	5 years
Proceeds from warrants								$ 4,320
Over-Allotment Option [Member]
Proceeds from sale of common stock \| shares							432,000
Proceeds from issuance of common stock							$ 2,155,680
Private Placement [Member]
Proceeds from sale of common stock \| shares																	4,575,429
Proceeds from issuance of common stock						$ 7,200,000
Legal and due diligence expenses																			$ 220,000
December 2022 Private Placement [Member]
Proceeds from issuance of common stock	$ 8,000,000.0
Legal and due diligence expenses			$ 100,000
Accredited Investors [Member] \| Private Placement [Member]
Stock issued during period shares new issues \| shares																			2,229,950
Accredited Investors [Member] \| December 2022 Private Placement [Member]
Stock issued during period shares new issues \| shares		4,575,429
Warrants exercise price \| $ / shares		$ 1.75	$ 1.75
Warrants term		3 years	3 years
Share issued price per share \| $ / shares		$ 1.75	$ 1.75
Maximum [Member]
Cash, FDIC insured amount																		$ 250,000
Common Stock [Member]
Reverse stock split issued and outstanding										1-for-5
Stock issued during period shares new issues \| shares																			2,880,000
Issued during period value new issues																			$ 288
Issuance of convertible shares, shares \| shares																			1,345,468
Common Stock [Member] \| Maximum [Member]
Debt stated percentage					10.00%
Common Stock [Member] \| Minimum [Member]
Debt stated percentage					5.00%
Debt Modification Agreement [Member] \| Common Stock [Member]
Conversion price per share \| $ / shares					$ 4.00
Common stock shares issued \| shares					105,000
Issuance of stock repurchase \| shares					45,653
Debt Modification Agreement [Member] \| Common Stock [Member] \| Charles Fernandez [Member]
Issuance of stock repurchase \| shares					18,261
Debt Modification Agreement [Member] \| Common Stock [Member] \| Rodney Barreto [Member]
Issuance of stock repurchase \| shares					18,261
Securities Purchase Agreement [Member] \| Common Stock [Member] \| Charles Fernandez [Member]
Issued during period value new issues				$ 10,000,000.0														$ 1,000,000.0
Conversion price per share \| $ / shares																		$ 6.0
Debt Instrument, Description																		each Debenture will mature on the third anniversary of its issuance and bear interest at 5.0% per annum, payable quarterly. At the Company’s election, interest can be paid in cash, shares of Progressive Care’s common stock, or some combination thereof. Progressive Care has the right to prepay the Debenture at any time provided that it gives the Company seven (7) business days advance written notice, during which time the Company could elect to convert the Debenture to Progressive Care’s common stock. Upon the prepayment of a Debenture, Progressive Care will pay the Company an amount equal to the sum of: (i) all outstanding principal under such Debenture, plus (ii) all accrued and unpaid interest under such Debenture through the prepayment date, multiplied by (iii) 110%. While amounts are outstanding under a Debenture, Progressive Care will be subject to certain restrictive covenants, including with respect to the incurrence of indebtedness, the imposition of liens on Progressive Care’s assets, changes to the Progressive Care’s organization documents, etc.
Purchase Agreement [Member] \| Private Placement [Member]
Proceeds from sale of common stock \| shares																			2,229,950
Sale of stock price per share \| $ / shares																			$ 3.24
Convertible Debt [Member]
Principal amount					$ 2,800,000
Payment of convertible debt					1,000,000.0
Convertible Debt [Member] \| Fernandez and Barreto Agreement [Member]
Aggregate purchase price					2,300,000
Payment of convertible debt					$ 400,000
Series B Preferred Stock [Member]
Stock issued during period shares new issues \| shares					3,000
Aggregate purchase price \| $ / shares					$ 2,000
Issued during period value new issues					$ 6,000,000.0
Issuance of convertible shares, shares \| shares					500
Warrants exercise price \| $ / shares					$ 2,000
EClips Media Technologies, Inc [Member]
Reverse stock split issued and outstanding																effecting a 2:1 forward split
Great West Resources Inc [Member]
Reverse stock split issued and outstanding															1:150
Dawson James Securities Inc [Member] \| December 2022 Private Placement [Member]
Gross proceeds percentage		6.00%	6.00%
Dawson James Securities Inc [Member] \| December 2022 Private Placement [Member] \| Placement Agent Warrants [Member]
Warrants exercise price \| $ / shares		$ 1.75	$ 1.75
Warrants to purchase common stock \| shares		549,051	549,051
Dawson James Securities Inc [Member] \| Officers and Directors [Member] \| December 2022 Private Placement [Member]
Gross proceeds percentage		3.00%	3.00%